StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)

Close on Nov 17, 2026Market cap $14.40BP/E –Yield –

Glaukos total assets

Total assets on the balance sheet at the end of each period.

Glaukos's total assets was $979.53M at Sep 30, 2026. For fiscal 2025 it was $893.49M, down 8.3% from the year before. Over ten years it grew 22.6% a year on average. The highest annual figure on record is $1.05B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$893.49M-8.3%
FY2024Dec 31, 2024$974.76M+3.7%
FY2023Dec 31, 2023$940.41M-6.2%
FY2022Dec 31, 2022$1.00B-4.5%
FY2021Dec 31, 2021$1.05B+4.4%
FY2020Dec 31, 2020$1.01B+22.9%
FY2019Dec 31, 2019$818.40M+295.4%
FY2018Dec 31, 2018$206.97M+24.8%
FY2017Dec 31, 2017$165.84M+23.4%
FY2016Dec 31, 2016$134.37M+15.2%
FY2015Dec 31, 2015$116.66M+348.3%
FY2014Dec 31, 2014$26.02M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$979.53M-2.0%
Q2 FY2026Jun 30, 2026$920.52M-6.7%
Q1 FY2026Mar 31, 2026$893.33M-7.5%
Q4 FY2025Dec 31, 2025$893.49M-8.3%
Q3 FY2025Sep 30, 2025$999.38M+7.9%
Q2 FY2025Jun 30, 2025$986.96M+7.3%
Q1 FY2025Mar 31, 2025$966.18M+3.5%
Q4 FY2024Dec 31, 2024$974.76M+3.7%
Q3 FY2024Sep 30, 2024$926.54M-2.3%
Q2 FY2024Jun 30, 2024$919.68M-3.9%
Q1 FY2024Mar 31, 2024$933.34M-4.0%
Q4 FY2023Dec 31, 2023$940.41M-6.2%
Q3 FY2023Sep 30, 2023$948.63M-5.9%
Q2 FY2023Jun 30, 2023$956.74M-7.2%
Q1 FY2023Mar 31, 2023$972.59M-7.6%
Q4 FY2022Dec 31, 2022$1.00B-4.5%
Q3 FY2022Sep 30, 2022$1.01B-5.2%
Q2 FY2022Jun 30, 2022$1.03B-1.2%
Q1 FY2022Mar 31, 2022$1.05B+2.9%
Q4 FY2021Dec 31, 2021$1.05B+4.4%
Q3 FY2021Sep 30, 2021$1.06B+7.0%
Q2 FY2021Jun 30, 2021$1.04B+4.8%
Q1 FY2021Mar 31, 2021$1.02B+31.2%
Q4 FY2020Dec 31, 2020$1.01B+22.9%
Q3 FY2020Sep 30, 2020$994.51M+223.5%
Q2 FY2020Jun 30, 2020$995.73M+229.6%
Q1 FY2020Mar 31, 2020$779.72M+241.9%
Q4 FY2019Dec 31, 2019$818.40M+295.4%
Q3 FY2019Sep 30, 2019$307.44M+61.4%
Q2 FY2019Jun 30, 2019$302.09M+76.6%
Q1 FY2019Mar 31, 2019$228.04M+39.6%
Q4 FY2018Dec 31, 2018$206.97M+24.8%
Q3 FY2018Sep 30, 2018$190.50M+24.8%
Q2 FY2018Jun 30, 2018$171.09M+17.6%
Q1 FY2018Mar 31, 2018$163.35M+18.5%
Q4 FY2017Dec 31, 2017$165.84M+23.4%
Q3 FY2017Sep 30, 2017$152.61M–
Q2 FY2017Jun 30, 2017$145.53M–
Q1 FY2017Mar 31, 2017$137.90M–
Q4 FY2016Dec 31, 2016$134.37M–

More Glaukos figures

See a number that looks wrong?